Clinical Trial Results:
            A phase 1/2, open-label study of bosutinib administered in combination with capecitabine in subjects with solid tumor and ErbB2 negative locally advanced or metastatic breast cancer.
    
|     Summary | |
|     EudraCT number | 2009-011878-15 | 
|     Trial protocol | HU ES BE FR GB | 
|     Global completion date | 
                                    31 Mar 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    21 Mar 2016
                             | 
|     First version publication date | 
                                    11 Feb 2015
                             | 
|     Other versions | |
|     Summary report(s) | 3160A6-2208 EU Posting | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
